(Q80595806)
Statements
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma (English)
Melanie B Thomas
Katrina Glover
Xuemei Wang
Jeffrey Morris
Thomas Brown
Asif Rashid
Janet Dancey
James L Abbruzzese
1 September 2007